Literature DB >> 12061728

Intracarotid RMP-7 enhanced indocyanine green staining of tumors in a rat glioma model.

Gavin W Britz1, Saadi Ghatan, Alexander M Spence, Mitchel S Berger.   

Abstract

OBJECTIVE: The extent of resection in patients with primary brain tumors may affect the quality of life, time to tumor progression, and survival. Currently, the extent of resection during surgery is guided by the visual appearance and consistency of tumor, frozen sections of the margins, intraoperative ultrasound, and frameless navigational systems and intraoperative imaging modalities. A new method that enhances the visualization of an infiltrating tumor and its margins may further aid in obtaining a more complete resection. A study was thus undertaken to assess the staining of brain tumors using Indocyanine green (ICG), a water-soluble emerald green tricarbocynanine dye concomitantly with RMP-7, a bradykinin analog, that selectively increases vascular permeability in brain tumors.
METHODS: A syngeneic ethyl-nitrosourea-induced F-344 rat cell line (36B-10) was stereotactically implanted into 25 rats, and allowed to mature for 15-18 days. Intracarotid administration of 0.75 ml of RMP-7 at a standard dose of 0.4 microg/ml over 15 min was then infused. Varying doses of ICG (range, 0-60 mg/kg) were then injected 15 min after the RMP-7 infusion ended. The animals were sacrificed 15 min after the ICG infusion was completed, and the brains examined macroscopically and microscopically for evidence of tumor staining.
RESULTS: This study demonstrated consistent staining of the tumor at only slightly lower ICG doses than previously described, however uptake at the tumor margins was evident at much lower doses. Thus the combination of ICG and RMP-7 administered preoperatively may provide visual enhancement of an infiltrating tumor and its margins to help facilitate a radical tumor removal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061728     DOI: 10.1023/a:1015035213228

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  The handling of indocyanine green by the liver.

Authors:  G Paumgartner
Journal:  Schweiz Med Wochenschr       Date:  1975

2.  Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

Authors:  M Ammirati; N Vick; Y L Liao; I Ciric; M Mikhael
Journal:  Neurosurgery       Date:  1987-08       Impact factor: 4.654

3.  Intraoperative diagnostic and interventional magnetic resonance imaging in neurosurgery.

Authors:  V M Tronnier; C R Wirtz; M Knauth; G Lenz; O Pastyr; M M Bonsanto; F K Albert; R Kuth; A Staubert; W Schlegel; K Sartor; S Kunze
Journal:  Neurosurgery       Date:  1997-05       Impact factor: 4.654

4.  In vitro plasma metabolism of RMP-7.

Authors:  J A Straub; A Akiyama; P Parmar
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

5.  Scanning and transmission electron microscopy of cloned rat astrocytoma cells treated with dibutyryl cyclic AMP in vitro.

Authors:  A M Spence; P W Coates
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

6.  Diagnostic yield in CT-guided stereotactic biopsy of gliomas.

Authors:  G M Greene; P W Hitchon; R L Schelper; W Yuh; G N Dyste
Journal:  J Neurosurg       Date:  1989-10       Impact factor: 5.115

7.  Experience in "radical" surgery of supratentorial gliomas in adults.

Authors:  A Bricolo; S Turazzi; L Cristofori; M Gerosa; J C Grosslercher; A Talacchi; M Vitale
Journal:  J Neurosurg Sci       Date:  1990 Jul-Dec       Impact factor: 2.279

8.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Authors:  M S Berger; A V Deliganis; J Dobbins; G E Keles
Journal:  Cancer       Date:  1994-09-15       Impact factor: 6.860

9.  Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.

Authors:  T Inamura; T Nomura; R T Bartus; K L Black
Journal:  J Neurosurg       Date:  1994-11       Impact factor: 5.115

10.  Photoradiation therapy: current status and applications in the treatment of brain tumors.

Authors:  M K Cheng; J McKean; D Boisvert; J Tulip
Journal:  Surg Neurol       Date:  1986-05
View more
  11 in total

1.  Review of Neurosurgical Fluorescence Imaging Methodologies.

Authors:  Brian W Pogue; Summer Gibbs-Strauss; Pablo A Valdés; Kimberley Samkoe; David W Roberts; Keith D Paulsen
Journal:  IEEE J Sel Top Quantum Electron       Date:  2010-05       Impact factor: 4.544

2.  Targeted Blue Nanoparticles as Photoacoustic Contrast Agent for Brain Tumor Delineation.

Authors:  Aniruddha Ray; Xueding Wang; Yong-Eun Koo Lee; Hoe Jin Hah; Gwangseong Kim; Thomas Chen; Daniel A Orringer; Oren Sagher; Xiaojun Liu; Raoul Kopelman
Journal:  Nano Res       Date:  2011-09-26       Impact factor: 8.897

Review 3.  Nanotechnology applications for glioblastoma.

Authors:  Edjah K Nduom; Alexandros Bouras; Milota Kaluzova; Costas G Hadjipanayis
Journal:  Neurosurg Clin N Am       Date:  2012-06-14       Impact factor: 2.509

4.  Evans blue nanocarriers visually demarcate margins of invasive gliomas.

Authors:  Benjamin T Roller; Jennifer M Munson; Barunashish Brahma; Philip J Santangelo; S Balakrishna Pai; Ravi V Bellamkonda
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

Review 5.  Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.

Authors:  Mamta Wankhede; Alexandros Bouras; Milota Kaluzova; Costas G Hadjipanayis
Journal:  Expert Rev Clin Pharmacol       Date:  2012-03       Impact factor: 5.045

6.  A technical description of the brain tumor window model: an in vivo model for the evaluation of intraoperative contrast agents.

Authors:  Daniel A Orringer; Thomas Chen; Dah-Luen Huang; Martin Philbert; Raoul Kopelman; Oren Sagher
Journal:  Acta Neurochir Suppl       Date:  2011

7.  The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents.

Authors:  Daniel A Orringer; Thomas Chen; Dah-Luen Huang; William M Armstead; Benjamin A Hoff; Yong-Eun L Koo; Richard F Keep; Martin A Philbert; Raoul Kopelman; Oren Sagher
Journal:  Neurosurgery       Date:  2010-04       Impact factor: 4.654

8.  In vitro characterization of a targeted, dye-loaded nanodevice for intraoperative tumor delineation.

Authors:  Daniel A Orringer; Yong-Eun L Koo; Thomas Chen; Gwangseong Kim; Hoe Jin Hah; Hao Xu; Shouyan Wang; Richard Keep; Martin A Philbert; Raoul Kopelman; Oren Sagher
Journal:  Neurosurgery       Date:  2009-05       Impact factor: 4.654

9.  Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy.

Authors:  D A Orringer; Y E Koo; T Chen; R Kopelman; O Sagher; M A Philbert
Journal:  Clin Pharmacol Ther       Date:  2009-02-25       Impact factor: 6.875

Review 10.  Nanomedicine: a primer for surgeons.

Authors:  K K Y Wong; X L Liu
Journal:  Pediatr Surg Int       Date:  2012-08-15       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.